JOURNAL OF CHILEAN CHEMICAL SOCIETY

Vol 64 No 3 (2019): Journal of the Chilean Chemical Society
Original Research Papers

ANTIMICROBIAL ACTIVITY AND IN SILICO STUDY OF METHYLIMIDAZOLIUM-FURANCHALCONE HYBRIDS AND 1-ALKYL-3-METHYLIMIDAZOLIUM SALTS

Pedronel Araque
Grupo de Investigación e Innovación en Formulaciones Químicas, University EIA
Angie Herrera
Química de Plantas Colombianas, Inst i tute of Chemistry, Universi ty of Antioquia – UdeA
Diego Montaño
Corporación Universi taria Americana, Sede Medellín
Andres Yepes
Química de Plantas Colombianas, Inst i tute of Chemistry, Universi ty of Antioquia – UdeA
Elisa García
Química de Plantas Colombianas, Inst i tute of Chemistry, Universi ty of Antioquia – UdeA
Jovany Sepúlveda
Corporación Universi taria Americana, Sede Medellín
Sandra Torijano
Grupo de Investigación e Innovación en Formulaciones Químicas, University EIA
Wilson Cardona-G.
Química de Plantas Colombianas, Inst i tute of Chemistry, Universi ty of Antioquia – UdeA
Published October 30, 2019
Keywords
  • Antibacterial,
  • antifungal,
  • ionic liquid,
  • in silico study,
  • hybrid molecules
How to Cite
Araque, P., Herrera, A., Montaño, D., Yepes, A., García, E., Sepúlveda, J., Torijano, S., & Cardona-G., W. (2019). ANTIMICROBIAL ACTIVITY AND IN SILICO STUDY OF METHYLIMIDAZOLIUM-FURANCHALCONE HYBRIDS AND 1-ALKYL-3-METHYLIMIDAZOLIUM SALTS. Journal of the Chilean Chemical Society, 64(3), 4547-4552. Retrieved from https://www.jcchems.com/index.php/JCCHEMS/article/view/1318

Abstract

A set of methylimidazolium-furanchalcone hybrids and 1-alkyl-3-methylimidazolium salts were tested in order to find their antimicrobial activity against five gram
positive bacteria, two gram negative bacteria and three fungi. In the series of 1-alkyl-3-methylimidazolium salts, compounds 4 and 7 were the most active compounds
against S. mutans and F. oxysporum, respectively (MIC value of 3.0 and 6.7 mM, respectively). In addition, among the hybrid molecules, compound 10 exhibited the
highest activity against F. solani (MIC50 = 14.3 mM) followed by hybrid 11 (MIC50 = 14.5 mM), which was also the most active against S. aureus, S. mutans (MIC50
= 14.6, 18.7 mM, respectively). The activity of these hybrids was even better with regard to the lead compounds (furanchalcone, methylimidazole or the mixture). In
the structure-activity relationship there was observed higher bioactivity when the alkyl linker had eigth carbon atoms. This was then supported by the in silico study
which displayed a strong relationship between the length of the alkyl chain on N and the biological activity. The results highlight the importance of these derivatives
(1-alkyl-3-methylimidazolium salts) and hybrids (methylimidazolium-furanchalcone) as potential antimicrobial agents.

99.jpg

References

1. As antibiotic discovery stagnates, IDSA; 2004.

2. S.J. Howard, M. Catchpole, J. Watson, S.C. Davies, Lancet Infect. Dis., 13, 1001, (2013).

3. R. Laxminarayan, A. Duse, C. Wattal, A.K. Zaidi, H.F. Wertheim, N. Sumpradit, E. Vlieghe, G.L.Hara, I.M. Gould, H. Goossens, C. Greko, A.D. So, M. Bigdeli, G. Tomson, W. Woodhouse, E. Ombaka, A.Q. Peralta, F.N. Qamar, F. Mir, S. Kariuki, Z.A. Bhutta, A. Coates, R. Bergstrom, G.D.Wright, E.D. Brown, O. Cars, Lancet Infect. Dis. 3, 1057, (2013).

4. H.W. Boucher, G.H. Talbot, J.S. Bradley, J.E. Edwards, D. Gilberto, L.B. Rice, M. Scheld, B. Spellberg, J. Bartlett, Clin. Infect. Dis. 48, 1, (2009).

5. R.D. Cannon, E. Lamping, A.R. Holmes, K. Niimi, P.V. Baret, M.V. Keniya, K. Tanabe, M. Niimi, A. Goffeau, B.C. Monk, Clin. Microbiol. Rev. 22, 291, (2009).

6. P.G. Pappas, C.A. Kauffman, D. Andes, D.K. Benjamin Jr, T.F. Calandra, J.E. Edwards Jr, S.G. Filler, J.F. Fisher, B.J. Kullberg, L.O. Zeichner, C. Reboli, J.H. Rex, T.J. Walsh, J.D. Sobe. Clin. Infect. Dis. 48, 503 (2009).

7. J.M. Achkar, B.C. Fries. Clin. Microbiol. Rev. 23, 253 (2010).

8. M.K. Kathiravana, A.B. Salake, A.S. Chothe, P.B. Dudhea, R.P. Watodea, M.S. Muktaa, S. Gadhwea. Bioorg. Med. Chem. 20, 5678 (2012).

9. L. De Luca. Curr Med Chem 13, 1 (2006).

10. L. Zhang, X.M. Peng, G.L.V. Damu, R.X. Geng, C.H. Zhou. Med. Res. Rev. 34, 340 (2014).

11. D. Zampieri, M.G. Mamolo, L. Vio, E. Banfi, G. Scialino, M. Fermeglia, M. Ferrone, S. Pricl. Bioorg. Med. Chem. 15, 7444 (2007).

12. J. Gising, M.T. Nilsson, L.R. Odell, S. Yahiaoui, M. Lindh, H. Iyer, A.M. Sinha, B.R. Srinivasa, M. Larhed, S.L. Mowbray, A.J. Karlén. Med. Chem. 55, 2894 (2012).

13. A. Puratchikodya, M. Doble, Bioorg. Med. Chem. 15, 1083 (2007).

14. R. Selig, M. Goettert, V. Schattel, D. Schollmeyer, W. Albrecht, S. Laufer, J. Med. Chem. 55, 8429 (2012).

15. J. Pandey, V.K. Tiwari, S.S. Varma, V. Chaturvedi, S. Bhatnagar, S. Sinha, A.N. Gaikwad, R.P. Tripathi. Eur. J. Med. Chem. 44, 3350 (2009).

16. G. La Regina, F.D. D’Auria, A. Tafi, F. Piscitelli, S. Olla, F. Caporuscio, L. Nencioni, R. Cirilli, F. La Torre, N.R. De Melo, S.L. Kelly, D.C. Lamb, M. Artico, M. Botta, A.T. Palamara, R. Silvestri, J. Med. Chem. 51, 3841 (2008).

17. R.A. Al-Qawasmeh, M. Huesca, V. Nedunuri, R. Peralta, J. Wright, Y. Lee, Y. Young, Bioorg. Med. Chem. Lett. 20, 3518 (2010).

18. A. Cornellas, L. Perez, F. Comelles, I. Ribosa, A. Manresa, M.T. Garcia, J. Colloid Interface Sci. 355, 164 (2011).

19. P. Borowiecki, M. Milner-Krawczyk, D. Brzezinska, M. Wielechowska, J. Plenkiewicz, Eur. J. Org. Chem. 4, 712 (2013).

20. P. Mester, M. Wagner, P. Rossmanith. Ecotoxicol. Environ. Saf. 111, 96 (2015).

21. J. Yu, S. Zhang, Y. Dai, X. Lu, Q. Lei, W. Fang, J. Hazard Mater 307, 73 (2016).

22. J. Pernak, K. Sobaszkiewicz, I. Mirska, Green Chem. 5, 52 (2003).

23. D. Demberelnyamba, K.S. Kim, S.J. Choi, S.Y. Park, H. Lee, C.J. Kim, I.D. Yoo, Bioorg. Med. Chem. 12, 853 (2004).

24. A. Romero, A. Santos, J. Tojo, A. Rodriguez, J, Hazard Mater., J. Hazard Mater. 151, 268 (2008).

25. M.T. Garcia, N. Gathergood, P.J. Scammells, Green Chem. 7, 9 (2005).

26. J. Luczak, C. Jungnickel, I. Lacka, S. Stolte, J. Hupka. Green Chem. 12, 593 (2010).

27. a) A. Budhiraja, K. Kadian, M. Kaur, V. Aggarwal, A. Garg, S. Sapra, K. Nepali, O.P. Suri, K.L. Dhar, Med. Chem. Res. 21, 2133 (2012) b) S. Kantevari, D. Addla, P.K. Bagul, B. Sridhar, S.K. Banerjee. Bioorg. Med. Chem. 19, 4772 (2011) c) S.U.F. Rizvi, H.L. Siddiqui, M. Johns, M. Detorio, R.F. Schinazi, Med. Chem. Res. 21, 3741 (2012) d) D.A. Israf, T.A. Khaizurin A. Syahida, N.H. Lajis, S. Khozirah. Mol. Immunol. 44, 673 (2007) e) N. Aoki, M. Muko, E. Ohta, S. Ohta. J. Nat. Prod. 71, 1308 (2008) f) V. Tomar, G. Bhattacharjee, Kamaluddin, S. Rajakumar, K. Srivastava, S.K. Puri, Eur. J. Med. Chem. 45, 745 (2010) g) M. Chen, S.B. Christensen, J. Blom, E. Lemmich, L. Nadelmann, K. Fich, T.G. Theander, A. Kharazmi. Antimicrob. Agents Chemother. 37, 2550 (1993) h) M.I. Abdullah, A. Mahmood, M. Madni, S. Masood, M. Kashif, Bioorg. Chem. 54, 31 (2014) g) K.V. Lahtchev, D.I. Batovska, S.P. Parushev, V.M. Ubiyvovk, A.A. Sibirny, Eur. J. Med. Chem. 43, 2220 (2008).

28. M.A.Munawar, M. Azad, H.L. Siddiqui, J. Chin. Soc. 55, 394 (2008).

29. M. Azad, M.A. Munawar, H.L. Siddiqui, J. Appl. Sci. 7, 2485 (2007).

30. R. Kalirazan; S.U. Sivakumar, S. Julie, B. Gowramma, B. Suresh, Int. J. Chemtech. Res. 1, 27 (2009).

31. S.N. Lopez, V. Marıa Castelli, S.A. Zacchino. Bioorg. Med. Chem. 9, 1999 (2001).

32. C.T. Keith, A. Borisy, B.R. Stockwell. Nat. Rev. Drug Discov. 4, 71 (2005).

33. B. Meunier, Acc. Chem. Res. 41, 69 (2008).

34. I. Opsenica, D. Opsenica, C.A. Lanteri, L. Anova, W.K. Milhous, K.S. Smith, B.A. Solaja, J. Med.Chem. 51, 6216 (2008).

35. B.L. Roth, D.J. Sheffler, W.K. Kroeze, Nat. Rev. Drug Discov. 3, 353 (2004).

36. J.J. Walsh, D. Coughlan, N. Heneghan, C. Gaynor, A. Bell, Bioorg. Med. Chem. Lett. 17, 3599. (2007).

37. P. Araque, C. Peláez, Revista Vitae 17, 83 (2010).

38. A.W. Bauer, W.M.M. Kirby, J.C. Sherris, M. Turck. Am. J. Clin. Pathol. 45, 493 (1966).

39. E.P. Abraham, A.D. Gardner, E.B. Chain, N.G. Heatley, C.M. Fletcher, M.A. Jennings, H.W. Florey, Lancet ii, 177 (1941).

40. I. Hossain, M.E. Harbawi, Y.A. Noaman, M.A.B. Bustam, N.B.M. Alitheen, N.A. Affandi, G. Hefter, C.Y. Yin. Chemosphere 84, 101 (2011).

41. K. Silva, S. Rodrigues, L. Filho, A. Lima, Appl. Biochem. Biotechnol. 152, 316 (2009).

42. Finney, D. J., 3rd Ed. (1971). Probit Analysis. Cambridge, England, Cambridge University Press.

43. Y. Zhao, M.H. Abraham, J. Lee, A. Hersey, N.C. Luscombe, G. Beck, B. Sherborne, I. Cooper, Pharm. Res. 19, 1446 (2002).

44. B.C. Ranu, S. Banerjee, Org. Lett. 7, 3049 (2005).

45. S.L. Fulmer, D.P. Richardson, T.E. Smith, S. Wolff, Org. Synth. 79, 236 (2002).

46. D.F. Montaño, H. Casanova, W.I. Cardona, L.F. Giraldo, Mater. Chem. Phys. 198, 386 (2017).

47. E. García, J.C. Coa, E. Otero, M. Carda, I.D. Vélez, S.M. Robledo, W.I. Cardona. Med. Chem. Res. 27, 497 (2018).

48. C.D. Sumi, B.W. Yang, I.C. Yeo, Y.T. Hahm, Can. J. Microbiol. 61, 93 (2015).

49. N. Kazuhiko, N. Ryota, O. Takashi, Jpn Dent Sci Rev 44, 29 (2008).

50. B. Yoo, B. Jing, S.E. Jones, G.A. Lamberti, Y. Zhu, J.K. Shan, E.J. Maginn, Sci. Rep. 6, 19889 (2016).

51. B.J. Denny, L. Novotny, P.W.J. West, M. Blesova, J. Zamocka, Med. Princ. Pract. 14, 377 (2005).

52. C.A. Lipinski, F. Lombardo, B.W. Dominy, P.J. Feeney, Adv. Drug Deliv. Rev. 23, 3 (1997).

53. P. Ertl, B. Rohde, P. Selzer. J. Med.Chem. 43, 3714 (2000).

54. a) N. Yang, M. Hinner, Methods Mol. Biol. 1266, 29 (2015) b) J.T. Gannon, V.B. Manilal, M. Alexander, Appl. Environ. Microbiol. 57, 190 (1991) c) K.M, Małgorzata, Z. Andrzej, R.G. Anna, L. Katarzyna, S. Leon, Microbiology 147, 2769 (2001) d) D.F. Veber, S.R. Johnson, H.Y. Cheng, B.R. Smith, K.W. Ward, K.D. Kopple. J. Med. Chem. 45, 2615 (2002).

Copyright @2019 | Designed by: Open Journal Systems Chile Logo Open Journal Systems Chile Support OJS, training, DOI, Indexing, Hosting OJS

Code under GNU license: OJS PKP